These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10563399)

  • 1. Structural changes induced by mupirocin in Staphylococcus aureus cells.
    Thomas DG; Hann AC; Day MJ; Wilson JM; Russell AD
    Int J Antimicrob Agents; 1999 Sep; 13(1):9-14. PubMed ID: 10563399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mupirocin resistance among Malaysian isolates of methicillin-resistant Staphylococcus aureus.
    Norazah A; Koh YT; Ghani Kamel A; Alias R; Lim VK
    Int J Antimicrob Agents; 2001 May; 17(5):411-4. PubMed ID: 11337230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mupirocin resistance in staphylococci: development and transfer of isoleucyl-tRNA synthetase-mediated resistance in vitro.
    Thomas DG; Wilson JM; Day MJ; Russell AD
    J Appl Microbiol; 1999 Apr; 86(4):715-22. PubMed ID: 10212417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical basis of mupirocin resistance in strains of Staphylococcus aureus.
    Farmer TH; Gilbart J; Elson SW
    J Antimicrob Chemother; 1992 Nov; 30(5):587-96. PubMed ID: 1493977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin.
    Palepou MF; Johnson AP; Cookson BD; Beattie H; Charlett A; Woodford N
    J Antimicrob Chemother; 1998 Nov; 42(5):577-83. PubMed ID: 9848440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level mupirocin resistance among Spanish methicillin-resistant Staphylococcus aureus.
    Alarcón T; Sanz JC; Blanco F; Domingo D; López-Brea M
    Eur J Clin Microbiol Infect Dis; 1998 Dec; 17(12):877-9. PubMed ID: 10052555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.
    Woodford N; Afzal-Shah M; Warner M; Livermore DM
    J Antimicrob Chemother; 2008 Oct; 62(4):766-8. PubMed ID: 18567573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mupirocin resistance in clinical isolates of Staphylococcus aureus.
    Jones PG; Sura T; Harris M; Strother A
    Infect Control Hosp Epidemiol; 2003 Apr; 24(4):300-1. PubMed ID: 12725362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of mupirocin E-test for susceptibility testing of Staphylococcus aureus.
    Mondino PJJ; Netto Dos Santos KR; do Carmo de Freire Bastos M; Giambiagi-deMarval M
    J Med Microbiol; 2003 May; 52(Pt 5):385-387. PubMed ID: 12721313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1985 May; 15(5):523-31. PubMed ID: 3924877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mupirocin resistance in methicillin-resistant Staphylococcus aureus from a veterans hospital.
    Naguib MH; Naguib MT; Flournoy DJ
    Chemotherapy; 1993; 39(6):400-4. PubMed ID: 8222867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus highly resistant to mupirocin is now common in Auckland.
    Skellem P; Toy G; Lang S
    N Z Med J; 1998 Mar; 111(1061):82. PubMed ID: 9549560
    [No Abstract]   [Full Text] [Related]  

  • 13. Mupirocin resistance of methicillin resistant staphylococcus aureus in Saudi Arabia.
    Rich M; Bannatyne RM; Memish ZA
    J Chemother; 1999 Oct; 11(5):414-5. PubMed ID: 10632391
    [No Abstract]   [Full Text] [Related]  

  • 14. Subinhibitory Concentrations of Mupirocin Stimulate Staphylococcus aureus Biofilm Formation by Upregulating
    Jin Y; Guo Y; Zhan Q; Shang Y; Qu D; Yu F
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31932378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of high-level mupirocin-resistant Staphylococcus aureus in a tertiary care facility.
    Irizarry L; Rupp J; Griffith J
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1967-8. PubMed ID: 8843318
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001.
    Kresken M; Hafner D; Schmitz FJ; Wichelhaus TA;
    Int J Antimicrob Agents; 2004 Jun; 23(6):577-81. PubMed ID: 15194128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases.
    Gilbart J; Perry CR; Slocombe B
    Antimicrob Agents Chemother; 1993 Jan; 37(1):32-8. PubMed ID: 8431015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of mupirocin and an isoflavanone isolated from Erythrina variegata on growth and recovery of methicillin-resistant Staphylococcus aureus.
    Sato M; Tanaka H; Yamaguchi R; Kato K; Etoh H
    Int J Antimicrob Agents; 2004 Sep; 24(3):241-6. PubMed ID: 15325427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of mupirocin against methicillin-resistant Staphylococcus aureus isolated from a hospital in Spain.
    Alarcón T; Domingo D; del Rey MC; López S; Sánchez I; López-Brea M
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):398-9. PubMed ID: 9758279
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mupirocin resistant MRSA in Japan].
    Kikuchi K
    Nihon Rinsho; 2001 Apr; 59(4):724-7. PubMed ID: 11304996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.